BCL2 Regulation according to Molecular Subtype of Breast Cancer by Analysis of The Cancer Genome Atlas Database
Ki-Tae Hwang, Kwangsoo Kim, Ji Hyun Chang, Sohee Oh, Young A Kim, Jong Yoon Lee, Se Hee Jung, In Sil Choi
Cancer Res Treat. 2018;50(3):658-669. Published online 2017 Jul 4 DOI: https://doi.org/10.4143/crt.2017.134
|
Citations to this article as recorded by
AL16ALA-SOD2 polymorphism predicts recurrence risk of breast cancer in patients treated with adjuvant tamoxifen
Maiquidieli Dal Berto, Laura Martin Manfroi, Aniúsca Vieira dos Santos, Giovana Tavares dos Santos, Gabriela Krüger da Costa, Camila Macedo Boaro, Péttala Rigon, Rafael José Vargas Alves, Claudia Giuliano Bica
Advances in Cancer Biology - Metastasis.2023; 8: 100108. CrossRef Clinicopathological features and prognosis of patients with HER2-low breast cancer
Xin Yang, Yao Li, Xu lu, Xiaotian Ren, Bin Hua
BMC Cancer.2023;[Epub] CrossRef Development of a prediction model for radiotherapy response among patients with head and neck squamous cell carcinoma based on the tumor immune microenvironment and hypoxia signature
Guang‐Li Zhu, Kai‐Bin Yang, Cheng Xu, Rui‐Jia Feng, Wen‐Fei Li, Jun Ma
Cancer Medicine.2022; 11(23): 4673. CrossRef Significance of Bcl-2 expression in breast cancer
Nitika Kumari, Natarajan Suresh, Josephine A.
Biomedicine.2022; 42(4): 775. CrossRef Detecting the expression of HRs and BCL2 via IHC can help identify luminal A-like subtypes of triple-positive breast cancers
Yingying Xu, Yonghao Liang, Guanghao Yin
Clinical and Translational Oncology.2022; 25(4): 1024. CrossRef Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft
Lorena Landuzzi, Arianna Palladini, Claudio Ceccarelli, Sofia Asioli, Giordano Nicoletti, Veronica Giusti, Francesca Ruzzi, Marianna L. Ianzano, Laura Scalambra, Roberta Laranga, Tania Balboni, Maddalena Arigoni, Martina Olivero, Raffaele A. Calogero, Car
Scientific Reports.2021;[Epub] CrossRef Prognostic influences of BCL1 and BCL2 expression on disease-free survival in breast cancer
Ki-Tae Hwang, Young A. Kim, Jongjin Kim, Hyeon Jeong Oh, Jeong Hwan Park, In Sil Choi, Jin Hyun Park, Sohee Oh, Ajung Chu, Jong Yoon Lee, Kyu Ri Hwang
Scientific Reports.2021;[Epub] CrossRef p53 and BLC2 Immunohistochemical Expression Across Molecular Subtypes in 1099 Early Breast Cancer Patients With Long-Term Follow-up: An Observational Study
Alessandra Fabi, Marcella Mottolese, Anna Di Benedetto, Francesca Sperati, Cristiana Ercolani, Simonetta Buglioni, Cecilia Nisticò, Gianluigi Ferretti, Patrizia Vici, Letizia Perracchio, Paola Malaguti, Michelangelo Russillo, Claudio Botti, Edoardo Pescar
Clinical Breast Cancer.2020; 20(6): e761. CrossRef Methylation of the NT5E Gene Is Associated with Poor Prognostic Factors in Breast Cancer
Young Ju Jeong, Hoon Kyu Oh, Hye Ryeon Choi, Sung Hwan Park
Diagnostics.2020; 10(11): 939. CrossRef Differential responses of epithelial cells from urinary and biliary tract to eggs of Schistosoma haematobium and S. mansoni
Rafael Nacif-Pimenta, Alessandra da Silva Orfanó, Ilana A. Mosley, Shannon E. Karinshak, Kenji Ishida, Victoria H. Mann, Paulo Marcos Zech Coelho, José M. Correia da Costa, Michael H. Hsieh, Paul J. Brindley, Gabriel Rinaldi
Scientific Reports.2019;[Epub] CrossRef A CTC-Cluster-Specific Signature Derived from OMICS Analysis of Patient-Derived Xenograft Tumors Predicts Outcomes in Basal-Like Breast Cancer
Hariprasad Thangavel, Carmine De Angelis, Suhas Vasaikar, Raksha Bhat, Mohit Kumar Jolly, Chandandeep Nagi, Chad J. Creighton, Fengju Chen, Lacey E. Dobrolecki, Jason T. George, Tanya Kumar, Noor Mazin Abdulkareem, Sufeng Mao, Agostina Nardone, Mothaffar
Journal of Clinical Medicine.2019; 8(11): 1772. CrossRef
BCL2L12: a multiply spliced gene with independent prognostic significance in breast cancer
Athina Kladi-Skandali, Diamantis C. Sideris, Andreas Scorilas
Clinical Chemistry and Laboratory Medicine (CCLM).2018; 57(2): 276. CrossRef
|